Idiopathic Pulmonary Fibrosis (IPF) – weathering the pandemic
Report on the ATTRACT study
Idiopathic Pulmonary Fibrosis: 5 Things to Know
Patient insights to shape development of a dCBT for IPF patients
C21 shows promise against COVID-19 where other drugs have failed